4.4 Review

Redox Regulation of Cancer Metastasis: Molecular Signaling and Therapeutic Opportunities

Journal

DRUG DEVELOPMENT RESEARCH
Volume 75, Issue 5, Pages 331-341

Publisher

WILEY
DOI: 10.1002/ddr.21216

Keywords

cancer therapy; metastasis; reactive oxygen species; redox sensors

Funding

  1. National 973 Basic Research Program of China [2013CB911300, 2012CB518900, 2011CB910703]
  2. National Science and Technology Major Project [2012ZX09501001-003]
  3. Chinese NSFC [J1103518]
  4. Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1400207]

Ask authors/readers for more resources

Cancer metastasis is the major cause of cancer-related mortality. Accumulated evidence has shown that high-metastasis potential cancer cells have more reactive oxygen species (ROS) accumulation compared with low-metastasis potential cancer cells. ROS can function as second messengers to regulate multiple cancer metastasis-related signaling pathways via reversible oxidative posttranslational modifications of cysteine in key redox-sensitive proteins, which leads to the structural and functional change of these proteins. Because ROS can promote cancer metastasis, therapeutic strategies aiming at inducing/reducing cellular ROS level or targeting redox sensors involved in metastasis hold great potential in developing new efficient approaches for anticancer therapy. In this review, we summarize recent findings on regulation of tumor metastasis by key redox sensors and describe the potential of targeting redox signaling pathways for cancer therapy. (C) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available